AMBEV S.A. current report, Q1 FY2016

Full document

Business Context and Reporting Period

This Form 6-K filing by AMBEV S.A. covers the month of February 2016, with the report signed on March 10, 2016. The filing is submitted pursuant to Rule 13a-16 of the Securities Exchange Act of 1934 and complies with Article 11 of CVM Instruction # 358/2002. The document specifically details transactions regarding the company's own securities and derivatives, focusing on treasury stock movements and American Depositary Receipts (ADRs).

Key Financial Metrics

The filing does not provide standard financial performance metrics such as revenue, profit, cash flow, margins, debt, or liquidity. Instead, it reports on specific treasury share transactions:

  • Treasury Shares (Initial Balance): 31,684,981 shares (0.2016% of total shares).
  • Treasury Shares (Final Balance): 31,465,305 shares (0.2002% of total shares).
  • Net Treasury Change: Decrease of 219,676 shares.
  • ADR Holdings: 0 shares (no change).

Material Changes and Transactions

The filing details specific transactions involving the company's common shares during February 2016:

  • Sales (Exercise of Options): The company sold a total of 296,675 shares directly to the company via option exercises.
    • Transaction dates: Feb 4, 25, 26, and 29.
    • Total volume: R$ 1,480,056.34.
    • Prices ranged from R$ 0.64106 to R$ 9.35960 per share.
  • Purchases (Share Acquisition Plan): The company purchased a total of 76,999 shares under a Share Acquisition Plan.
    • Transaction dates: Feb 4 and 26.
    • Total volume: R$ 1,362,330.81.
    • Prices were R$ 18.36 and R$ 17.63 per share.

Guidance, Outlook, and Risks

The filing text does not provide management commentary, financial guidance, outlook, risk factors, or contingencies. The document is strictly a regulatory disclosure of securities transactions required by Brazilian securities regulations (CVM Instruction # 358/2002).

Investor Verification Checklist

  • Verify the impact of the net reduction in treasury shares (219,676 shares) on the company's total outstanding share count.
  • Confirm the pricing variance in option exercises, which ranged significantly from R$ 0.64 to R$ 9.36.
  • Note that no ADR transactions occurred during the period.
  • Understand that this filing contains no operational or financial performance data for the period.